Zion Zibly, MD, MBA is an Associate Professor in the Department of Neurosurgery at Yale School of Medicine . He holds multiple leadership roles including Director of the Center of Neuromodulation , Director of the Center of Neurosurgical Cancer Pain , and Head of Stereotactic & Functional Neurosurgery and the Focused Ultrasound Institute . Previously served as Chair of Neurosurgery at Sheba Medical Center after graduating from Technion’s Faculty of Medicine (MD) and Coller School of Management (MBA). Research Interests: Specializes in Neuromodulation for movement disorders (Parkinson’s, tremors, dystonia), Deep Brain Stimulation , Gene Therapy for pediatric neurodegenerative conditions, Oncological Neurosurgery , and Neurological Pain Management . Combines Functional Neurosurgery with Focused Ultrasound technology. Scientific Contributions: Participated in pioneering Alzheimer’s brain stimulator procedures and Gene Therapy applications. Active member of the North American Association of Functional Neurosurgery and Israeli Neurosurgical Society . Clinical Expertise: Implantation of electrostimulators for Parkinson’s and essential tremor, treatment of Benign/Malignant CNS Tumors , and management of Neurological Pain Conditions . Affiliated with Yale Cancer Center and Center for Brain & Mind Health .
Raphael Franzini serves as Associate Professor of Medicinal Chemistry at the University of Utah, actively contributing to the Biological Chemistry PhD Program. His research pioneers innovative chemical approaches for therapeutic development, with dual focus on DNA-encoded library technologies and bioorthogonal drug delivery systems. His educational foundation includes an M.S. from the Swiss Federal Institute of Technology (Lausanne) and a Ph.D. from Stanford University. This training underpins his group's multidisciplinary methodology combining organic synthesis, bioconjugation, computational modeling, and advanced imaging techniques. Dr. Franzini's research program centers on two transformative areas: First, advancing DNA-encoded library screening through computational integration to identify leads for challenging targets like Tankyrase and Sirtuin 6, with recent work addressing false negatives in machine learning prediction. Second, developing novel bioorthogonal release chemistry using isonitrile-tetrazine reactions for spatiotemporally controlled drug activation, validated in zebrafish models. His group emphasizes both technological innovation and therapeutic translation, with chemistry designed to minimize off-target effects in solid tumors. Analysis of his 15 most recent publications reveals escalating integration of computational methods with experimental library screening, alongside refinement of bioorthogonal release kinetics. The work spans chemical biology, medicinal chemistry, and pharmaceutical sciences, with growing emphasis on machine learning for library data interpretation and in vivo validation of drug-release systems. Dr. Franzini maintains an active research laboratory that provides comprehensive training in cutting-edge drug discovery methodologies. His group culture prioritizes both scientific innovation and researcher development, with projects spanning from fundamental reaction kinetics to therapeutic applications. The lab's infrastructure supports organic synthesis, molecular imaging, and computational analysis for advancing precision therapeutics.
Ashis K. Patra is a full-time Professor in the Department of Chemistry at the Indian Institute of Technology Kanpur (IIT Kanpur). After obtaining his Ph.D. from the Indian Institute of Science (IISc) Bangalore in 2008, he carried out post-doctoral research at Harvard University and the University of Georgia before joining IIT Kanpur in 2012. Education & Academic Training Ph.D. (2008), Indian Institute of Science (IISc), Bangalore M.Sc. (2002), The University of Burdwan Research Interests Professor Patra leads an interdisciplinary program that sits at the interface of inorganic chemistry, chemical biology, and medicinal chemistry. His work is organized into three principal thrusts: Therapeutic Applications of Metal Complexes: Design and mechanistic evaluation of cytotoxic transition-metal complexes that target nucleic acids and proteins, aiming to overcome multidrug resistance in cancer. Nitric Oxide Delivery from Transition Metal Nitrosyls: Development of photo- and redox-triggered metal nitrosyl complexes for controlled NO release to biological targets such as hemoglobin, myoglobin, and glutathione. Luminescent Lanthanide Complexes: Synthesis and photophysical characterization of Eu(III) and Tb(III) complexes that serve as luminescent probes and theranostic agents. Research Output & Impact His group has published extensively in leading journals including Dalton Transactions , Inorganic Chemistry , Chemical Science , and Journal of Inorganic Biochemistry . The collective work demonstrates a clear trajectory from fundamental coordination chemistry to translational applications in drug delivery and bioimaging, with recurring themes of redox control, light activation, and biological targeting. Scientific Awards & Fellowships CSIR Junior & Senior Research Fellowships (2001, 2003) West Bengal SLET Qualification (2001) International Travel Grants from CSIR & INSA (2006) DST Fast-Track Fellowship for Young Scientists (2013) Erasmus Mundus NAMASTE Scholarship for Academic Staff (2014) JSPS Invitation Fellowship (2016) Teaching & Mentoring Professor Patra teaches core and advanced courses in inorganic chemistry, including Inorganic Chemistry Laboratory, Bioinorganic Chemistry, and Frontiers in Inorganic Chemistry. He actively mentors Ph.D. and master’s students (full list available on his lab website ) and has established the Laboratory of Inorganic Chemical Biology in the Old Core Lab complex at IIT Kanpur.
Christopher E. Nelson is an Assistant Professor in the Department of Biomedical Engineering at the University of Arkansas, College of Engineering. His lab focuses on developing biologically inspired strategies for controlled drug and gene delivery, particularly in the context of gene therapy and regenerative medicine. He is actively supported by the NIH, DoD, and Arkansas Bioscience Institute. Education: Postdoctoral Fellow – Duke University Ph.D. – Vanderbilt University B.S. – University of Arkansas Research Focus: Dr. Nelson’s lab integrates genome editing technologies with targeted delivery systems to address challenges in treating genetic diseases and promoting tissue regeneration. Major themes include CRISPR/Cas9 delivery , gene regulation in wound healing , and safe-harbor genome integration in skeletal muscle. His work spans viral and non-viral delivery vehicles , including lipid nanoparticles and AAV vectors, with a strong emphasis on preclinical validation in models of Duchenne muscular dystrophy and inflammatory disease. Scientific Awards: Controlled Release Society Postdoctoral Fellowship The Hartwell Foundation Postdoctoral Fellowship NIH Pathway to Independence Award (K99/R00) Funding & Support: The Nelson Lab is currently funded by: NIH NIGMS R35 DoD CDMRP DMD IDEA Award Arkansas Bioscience Institute University of Arkansas Engineering & Honors Colleges Lab & Team: The Nelson Lab is a dynamic, interdisciplinary team working at the intersection of gene editing, biomaterials, and regenerative medicine. They regularly present at national conferences such as ASGCT and NCUR, and mentor undergraduate researchers through SURF and Honors College grants.
Jonathan Conway is an Assistant Professor in the Department of Chemical and Biological Engineering at Princeton University and an associated faculty member of the High Meadows Environmental Institute (HMEI). He leads the Conway Lab, which focuses on engineering plant-microbe interactions for applications in bioagriculture, bioenergy, and biochemical industries. Education: B.S. Chemical Engineering, University of Notre Dame (2011) M.S. Chemical Engineering, North Carolina State University (2013) Ph.D. Chemical Engineering, North Carolina State University (2017) Postdoctoral Fellow, University of North Carolina Chapel Hill & Howard Hughes Medical Institute (2017-2021) Research Interests: The Conway Lab develops genetic engineering approaches for non-model bacteria at plant-microbe interfaces. Key research areas include: chemical signaling between plants and microbes, microbiome impacts on plant immunity, environmental stress responses in agricultural systems, and enzymatic degradation of lignocellulosic biomass using thermophilic bacteria. The lab employs bacterial genetics, systems biology, and biomolecular engineering to create technologies for sustainable bioindustries. Publication Trends: Recent work demonstrates strong emphasis on molecular mechanisms of plant-microbe communication (2020-2024), enzyme characterization in biomass degradation (2024-2025), and development of synthetic microbial communities for climate resilience (2024). Earlier research focused on extremophile enzymology and metabolic engineering (2012-2019). Student Advising: Currently mentors 4 graduate students and 8 undergraduates. Alumni include 9 former advisees who graduated between 2022-2024. The lab actively recruits students through Princeton's Chemical Engineering graduate program and undergraduate research initiatives. Laboratory: The Conway Lab develops microfluidic systems for root microbiome studies and genetic tools for engineering plant-associated bacteria. Current projects include designing thermophilic microbial consortia for consolidated bioprocessing and characterizing bacterial immune evasion strategies.
Bilal Farooq is an Associate Professor and Program Director for the Master of Engineering in Interdisciplinary Engineering (MEIE) at Toronto Metropolitan University, holding the Canada Research Chair in Disruptive Transportation Technologies and Services within the Department of Civil Engineering. His educational background includes a PhD from the University of Toronto (2011), MASc from Lahore University of Management Sciences (2004), and BSc from the University of Engineering and Technology (2001). Dr. Farooq's research pioneers disruptive transportation solutions through cyber-physical systems, AI/machine learning applications, behavioral modeling, and optimization techniques. His work specifically targets on-demand multimodal systems, sustainable urban transportation, urban air mobility, automated vehicles, and extended reality applications, addressing critical urban mobility challenges with human-centered approaches. Analysis of his recent publications reveals a strong trend toward quantum-enhanced computational methods, privacy-preserving federated learning frameworks, and sustainability-focused decarbonization strategies across transportation domains, with increasing emphasis on human factors and real-world implementation. Notable scientific awards include: Ontario Early Researcher Award (2018) Canada Research Chair (2017) MassMotion Academic Pedestrian Modelling Project of the Year (2016) Québec Early Researcher Award (2014) Dr. Farooq actively supervises graduate students and secures significant research funding through his Canada Research Chair position and Early Researcher Awards. He directs the Laboratory of Innovations in Transportation (LiTrans), which develops interdisciplinary solutions integrating mathematics, engineering, computer science, and economics to address emerging transportation challenges. LiTrans focuses on disruptive transportation technologies, complete streets design, cyber-physical systems, pedestrian dynamics, resilience, and climate change impacts, collaborating with industry and government partners to translate research into practical urban mobility innovations for smart cities worldwide.
Minjie Chen is an Associate Professor of Electrical and Computer Engineering and the Andlinger Center for Energy and the Environment at Princeton University, serving as Acting Associate Director for Research at the Andlinger Center. He leads the Princeton Power Electronics Lab (PowerLab), which focuses on developing fundamental and novel power electronics solutions for a wide range of applications from mW-scale energy harvesting to MW systems in renewable energy integration. Dr. Chen received his Ph.D. in Electrical Engineering and Computer Science from MIT in 2015 and his B.S. in Electrical Engineering from Tsinghua University in 2009. Before joining Princeton as an Assistant Professor in February 2017, he was a postdoctoral associate at MIT Research Laboratory of Electronics. His research spans power electronics, magnetics design, and machine learning applications in energy systems. The PowerLab develops advanced power conversion architectures that enable order-of-magnitude higher power density through high-frequency designs, addressing circuit timing, parasitics, magnetics, and thermal management challenges. Their work targets applications ranging from portable devices to data centers and renewable energy systems. The research group has produced a remarkable series of high-impact publications, with seven IEEE Transactions on Power Electronics Prize Papers in seven consecutive years (2016-2023). Their recent work increasingly integrates machine learning techniques with power electronics, exemplified by the MagNet project which redefines how power magnetics are studied and modeled. NSF CAREER Award, 2019 IEEE PELS Richard M. Bass Outstanding Young Power Electronics Engineer Award, 2023 Power of Associations Silver Award from ASAE for MagNet project, 2024 Multiple IEEE Transactions on Power Electronics Prize Papers (2016-2023) Princeton Engineering Commendation List for Outstanding Teaching (2019, 2020) Dr. Chen advises approximately 15 graduate students who have received numerous awards including the IEEE PELS John G. Kassakian Fellowship, Princeton SEAS Honorific Fellowship, and multiple IEEE conference best paper awards. His research is supported by significant grants from NSF, DOE ARPA-E, Princeton Innovation Fund, C3.ai DTI, and industry partners including Intel, Google, and pSemi. The lab's MagNet project has become a major international initiative with a $60,000 prize pool challenge. The PowerLab maintains strong industry connections and has launched several collaborative projects with Intel, Google, and pSemi. Their MagNet project has evolved into an international challenge with participation from over 40 teams worldwide, demonstrating the growing impact of their approach to machine learning for power magnetics modeling.
Yevgeny Brudno, PhD, is an Associate Professor at the Eshelman School of Pharmacy (UNC-Chapel Hill) with a joint appointment in Biomedical Engineering (UNC and NC State University). He is a member of the UNC Lineberger Comprehensive Cancer Center and leads the Brudno Lab, which specializes in drug delivery and biomaterials for cancer immunotherapy, particularly CAR T cell therapy. Research Focus: Development of implantable biotechnologies for in vivo CAR-T cell production, biomaterials for therapeutic delivery, and click chemistry-based drug targeting. Education: PhD (unspecified institution). The lab’s research bridges chemical and biomaterials science with clinical needs, emphasizing on-demand drug release , solid tumor targeting , and autoimmune disease treatments . Recent work includes bioinstructive scaffolds and tissue-reactive drug depots , leveraging click chemistry and nanomedicine . His scientific contributions are highlighted by 15 publications (2009–2025) in fields like biotechnology, cancer immunotherapy, and epigenetics. Notable awards include the NCI MERIT Award , University Faculty Scholar (NC State), and Outstanding Teacher Award (NC State). Advising: Mentored 13 PhD and Master’s students, including Sharda Pandit (2023), Chris Moody (2021), and Emily Joe (2024). Lab announcements highlight student achievements like NSF and NIH fellowships. The Brudno Lab collaborates with UNC Lineberger and NC State, focusing on streamlining therapy production , enhancing efficacy in solid tumors , and autoimmune disease applications , supported by grants from NCI and CMI.
Chao Wang is an Associate Professor at the Department of Chemical and Biomolecular Engineering within the Whiting School of Engineering at Johns Hopkins University. He also serves as the Director of the Nano Energy Laboratory and the department’s Master’s Admissions Director. His research focuses on sustainable energy systems and nanomaterials for CO2 capture and conversion, electrocatalysis, thermocatalysis, and green chemical engineering. Education: Bachelor’s degree, University of Science and Technology of China (2004) Doctorate, Brown University (2009) Wang’s research targets efficient energy conversion and storage via nanomaterials with tailored atomic structures, emphasizing catalytic activity, selectivity, and stability. His group explores electrochemical and thermochemical processes for reduced carbon footprints, including CO2 and methane conversion, ammonia recovery, and phosphorus/nitrogen nutrient recycling using zeolite-based systems. Recent publications (2021–2024) highlight his work in high-entropy alloys, solid-state battery materials, CO2 electroreduction, and biomedical nanotechnologies. Collaborative efforts span catalysis, nanoparticle dynamics, and environmental applications. Grants include a $1M DOE award for multi-university research, a $625K DOE grant for electrified transportation systems, and $3M in startup funding for carbon-removal technology commercialization. Alumni under his mentorship include Ph.D. graduates like Michael J. Manto (2018) and Master’s students like Mitchell Keller (2018), with notable achievements in catalyst development for ammonia/phosphorus recovery and industry placements at Grace & Co. and GEA Engineering.
Senior Lecturer Outi Salo-Ahen is affiliated with Åbo Akademi University's Faculty of Natural Sciences and Engineering , Department of Pharmacy. Her research focuses on computational pharmacology, drug design, and pharmaceutical chemistry, particularly targeting chemokine receptors (CCR5/CXCR4) and transient receptor potential channels (TRPA1) for therapeutic applications. Doctor of Pharmacy (2006, University of Kuopio/UEF) MSc in Pharmaceutical Chemistry (2001, UEF) BSc in Pharmacy (1999, UEF) University Pedagogy Modules 1-5 (2012-2015) Her work contributes to UN Sustainable Development Goals through education and pharmaceutical innovation . Recent research trends include: Antimicrobial resistance solutions TRPA1 channel modulation Nanotechnology-enabled drug delivery Multi-target HIV-1 inhibitors 3D printing of biocompatible materials Computational analysis of nucleic acid frameworks She actively supervises doctoral projects, serves on assessment panels, and leads collaborations like Nordic Pharmaceutical Translation and Innovation. Her 60+ publications demonstrate expertise in molecular modeling and drug discovery.
Santiago F. González is a Group Leader at the Institute for Research in Biomedicine (IRB) in Bellinzona, Switzerland, and an extraordinary professor at the University of Italian Switzerland (USI). He earned dual PhDs in microbiology (University of Santiago de Compostela, Spain) and immunology (University of Copenhagen, Denmark), followed by postdoctoral work (2007–2011) at Harvard Medical School's Immune Disease Institute under Michael Carroll. PhD in Microbiology, University of Santiago de Compostela PhD in Immunology, University of Copenhagen His research focuses on immune system dynamics during respiratory viral infections, vaccination, and cancer metastasis. Key areas include influenza recognition , lymph node inflammation , and immune cell behavior in vivo. He pioneered studies on C-type lectin receptors (e.g., SIGN-R1) in viral immunity and epigenetic modulators for inflammation. Recent publications highlight his work in epigenetic drug development , nanovaccines , and computational tools for immune cell tracking. His group uses two-photon intravital microscopy and spatial-temporal modeling to dissect immune responses. Scientific awards include three EU Marie Curie Fellowships (2004–2013), enabling his transition to independent research. His collaborations span Harvard, USI, and European institutions, with grants from the EU and Swiss research bodies. His lab at IRB, established via the 2013 Marie Curie Career Integration Grant , develops novel imaging approaches and therapeutic strategies for infectious and immune-mediated diseases.
Li Tang is an Associate Professor with tenure at École polytechnique fédérale de Lausanne (EPFL), affiliated with the Institute of Bioengineering (IBI) and the Institute of Materials Science and Engineering (IMX) within the School of Engineering (STI). She leads the Laboratory of Biomaterials for Immunoengineering, focusing on developing innovative strategies at the intersection of immunology, materials science, and cancer therapy. Her work bridges fundamental research and clinical translation, with multiple ongoing clinical trials based on CAR-T cell therapies developed in her lab. B.S. in Chemistry, Peking University (2003–2007) Ph.D. in Materials Science and Engineering, University of Illinois at Urbana-Champaign (2007–2012) Postdoctoral Fellow, MIT (2013–2016) Her research lies at the forefront of immunoengineering, integrating chemical, metabolic, and mechanical approaches to modulate immune responses. Key areas include cancer immunotherapy, immune metabolism, mechano-immunology, and biomaterials. She investigates how physical and biochemical cues can reprogram T cells, overcome exhaustion, and enhance tumor targeting. Her work emphasizes multidimensional immunity-disease interactions, aiming to develop safer and more effective therapies for cancer and autoimmune diseases. The recent publications highlight a strong trend in engineering immune cells (especially CAR-T) for enhanced durability and function, using advanced biomaterials and metabolic reprogramming. There is a clear focus on overcoming challenges in solid tumors, modulating the tumor microenvironment, and translating findings into clinical applications. The use of nanoparticle delivery, single-cell analysis, and biomechanical cues are recurring themes across her work. Notable scientific awards include: Friedrich Miescher Award (2025) ERC Starting Grant (2018) MIT TR35 Innovators Under 35 (China Region, 2020) Nano Research Young Innovator Award (2018) Biomaterials Science Emerging Investigator (2019) Materials Horizons Emerging Investigator (2020) Li Tang actively mentors PhD students across multiple doctoral programs (EDBB, EDMS, EDMX) and has advised numerous graduates who have gone on to prestigious postdoctoral and faculty positions. She is involved in significant research grants, including an Innosuisse project with Novochizol SA, and her lab is supported by competitive funding. She teaches core courses such as Immunoengineering and Next-Generation Biomaterials, shaping the next generation of scientists. Her lab fosters interdisciplinary collaboration and innovation, with active projects in chemical, metabolic, and mechanical immunoengineering, as well as CAR-T cell development. She is the Principal Investigator of the Tang Lab, which includes postdoctoral fellows, PhD students, and technical staff. The lab is actively recruiting and has a strong publication and clinical translation record. Tang Lab is also involved in multiple MA/BA training projects and promotes student engagement in cutting-edge research. The lab’s discoveries are being translated into clinical trials, reflecting a strong commitment to translational science.
Jennica Zaro, PhD, serves as Associate Professor of Pharmacology and Pharmaceutical Sciences at the University of Southern California (USC) School of Pharmacy and Assistant Dean for Assessment in the Office of Graduate Education and Postdoctoral Studies. Previously, she held academic leadership roles at West Coast University School of Pharmacy and directed the Translational Research and Histology laboratories at USC Mann. Education: PhD in Pharmaceutical Sciences, University of Southern California BS, Stockton University Her pioneering research focuses on engineering recombinant fusion proteins for targeted drug delivery, particularly developing liver-specific insulin therapies for diabetes and pH-sensitive nanoconstructs for tumor targeting. This interdisciplinary work bridges protein engineering, nanomedicine, and translational pharmacology to create site-specific therapeutic systems with enhanced efficacy and reduced side effects. Analysis of her recent publications reveals a cohesive research trajectory centered on protein-drug conjugates, with significant contributions in pH-responsive delivery systems (2017-2018) and liver-targeted insulin analogs (2016-2018). Her work consistently appears in high-impact journals like Journal of Controlled Release and Biomaterials , demonstrating expertise in translating molecular designs into therapeutic applications. Scientific Awards: Most Innovative Award (2017, West Coast University) Advisor of the Year Award (2017, West Coast University, School of Pharmacy) Dr. Zaro has secured substantial research funding as Principal Investigator for NIH National Cancer Institute projects (2013-2016) and USC Ming Hsieh Institute grants (2014-2015), plus consultancy roles with Juvenile Diabetes Research Foundation (2016-2018). She actively shapes national research policy through service on NIH and UK Medical Research Council review panels and the American Foundation for Pharmaceutical Education Board of Grants. Her laboratory expertise includes the Translational Research and Histology core facilities at USC Mann, and she maintains active roles in professional organizations including the Controlled Release Society, American Association of Pharmaceutical Scientists, and American Association of Colleges of Pharmacy.
Constantine (Costa) Samaras is the Trustee Professor of Civil and Environmental Engineering and Director of the Wilton E. Scott Institute for Energy Innovation at Carnegie Mellon University. He is also affiliated with the Department of Engineering and Public Policy and holds a courtesy appointment in the Heinz College of Information Systems and Public Policy. Director, Scott Institute for Energy Innovation Trustee Professor, Civil and Environmental Engineering Affiliated Faculty, Engineering and Public Policy Courtesy Faculty, Heinz College of Information Systems and Public Policy His research focuses on systems engineering approaches to climate resilience , clean energy transitions , and infrastructure security . Key areas include: Transportation electrification and automation Climate adaptation for infrastructure Energy policy under uncertainty AI impacts on energy systems Equity in decarbonization National security implications of energy Costa Samaras co-authored 15 recent studies spanning energy burden analysis, climate hazard indices, AI training energy optimization, and nature-based infrastructure solutions. His work emphasizes transdisciplinary collaboration between engineering, policy, and climate science. Notable scientific recognition includes being named Professor of the Year by the Pittsburgh Section of the American Society of Civil Engineers in 2018. He has led significant policy engagements including White House service (2021-2024) as Principal Assistant Director for Energy and Chief Advisor for Clean Energy Transition. Current affiliations include: Founder/Director, Center for Engineering and Resilience for Climate Adaptation Founder/Director, Power Sector Carbon Index Former Senior Researcher, RAND Corporation (2009-2014) Former Adjunct Senior Analyst, RAND Corporation (2014-2021)
Dr Virginia Hagger is a Senior Lecturer in Nursing at Deakin University's School of Nursing & Midwifery, part of the Faculty of Health and the Institute for Health Transformation. She specializes in diabetes education, self-management, and psychological wellbeing. Her research focuses on structured education programs, diabetes distress, and workforce development. She holds a PhD and Master of Public Health from Deakin University. Dr Hagger has led numerous national and international studies, including interventions targeting diabetes distress, insulin therapy barriers, and telehealth support. She is affiliated with the Quality and Patient Safety (QPS) Strategic Research Centre and the Australian Centre for Behavioural Research in Diabetes . Awards include the 2019 Alfred Deakin Medal and 2017 Vice-Chancellor's Award for Teaching Excellence. Her teaching spans undergraduate and postgraduate nursing, including units on diabetes pathophysiology and psychosocial contexts. Current doctoral students focus on diabetes distress, social support in Ethiopia, and autonomy in insulin management. Over 30 peer-reviewed articles and grants (e.g., MRFF-funded HypoPAST and LISTEN trials) underscore her contributions to diabetes care innovation and workforce training.
